Steris (STE) Tops Q3 EPS by 11c, provides guidance

Steris (NYSE: STE) reported Q3 EPS of $2.47, $0.11 better than the analyst estimate of $2.36. Revenue for the quarter came in at $1.46 billion versus the consensus estimate of $1.43 billion.

GUIDANCE:

Steris sees FY2025 EPS of $10.15-$10.30, versus the consensus of $10.09.

For earnings history and earnings-related data on Steris (STE) click here.

You May Also Be Interested In

• Aggreko files for proposed IPO
• Golden Spike Resources expands private placement to $975,000
• Co-Diagnostics (CODX) files for 3.4M share offering by selling stockholders